I'd like to cancel this standing order luteal estrace antagonist protocol for ivf The company's shares pared some of their early losses andwere down 5.9 percent at $64.97 on Nasdaq late in the day. (Additional reporting by Bobbi Rebell and Garima Goel; Editingby Janet Guttsman, Maureen Bavdek and Peter Galloway)